Currently undergoing Phase 3 trials in USA, Dr Fauci and the former head of ObamaCare both expect monoclonal antibody therapy to be ready in time for winter which should bridge the gap for vulnerable groups until vaccines are deployed.
Fauci expects results from clinical trial for COVID treatment by fall
Anthony Fauci discusses the need for monoclonal antibodies, proteins that could fight the coronavirus at multiple stages, in a Facebook Live interview
Antibody therapies could be a bridge to a coronavirus vaccine — but will the world benefit?
Monoclonal antibodies are complex and expensive to produce, meaning poor countries might be priced out.